ArticleFrontiers in immunology2023

Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.

Ivan Arisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.